Alumni Success: Belma Alispahic at the 9th Bioproduction Congress

We are proud to celebrate the success of Belma Alispahic, Chief Scientific Officer and Co-Founder of AnalysisMode, who recently had the opportunity to present at the prestigious 9th Bioproduction Congress (BIOPC 2024) in Tours, France.

Belma shared her groundbreaking insights on "Future-Proofing with AI-Powered Bioprocess Development", showcasing how AnalysisMode is revolutionizing biopharmaceutical workflows. The energy and innovation at BIOPC 2024 were recognizable, with AI taking center stage in reshaping the future of bioproduction.

As part of AnalysisMode, Belma and her team are tackling some of the most complex challenges in the biopharma industry by harnessing AI to drive efficiency, adaptability, and resilience in bioprocessing. Belma's participation in the congress reinforced one clear message: AI is rapidly becoming essential for staying ahead in the increasingly complex biopharma landscape.

Key Takeaway from Belma's Presentation:
"AI is transforming bioprocessing, and those who embrace it are poised for growth and innovation. We’re just scratching the surface of what’s possible with digital twins and process modeling."

Belma expressed her gratitude to everyone who attended her session and contributed to insightful discussions about the future of bioproduction. She remains excited to continue pushing the boundaries of innovation with her team at AnalysisMode and looks forward to future collaborations.

We are incredibly proud of Belma’s achievements and her role in shaping the future of biopharma with AI!